Hualan vaccine will miss you by subscribing to Morning One Fund

On August 25, Hualan Vaccine passed the meeting smoothly, and Hillhouse Capital and Morning One in 2020fundBuy shares, and subscribe to Morning One Fundreally miss you, Will also get tangible benefits.

　　Hualan vaccine meeting

　　Hillhouse Capital and Morning One Fund “make a profit”

On the evening of August 25, the Shenzhen Stock Exchange issued a notice showing that as the first share of Henan’s A-share spin-off and listing, Hualan Vaccine passed the meeting smoothly and is expected to become Henan’s first A-share spin-off and listed company. According to the prospectus, Hualan Vaccine plans to issue no more than 40.01 million shares and plans to raise 2.495 billion yuan.

According to data, Hualan Vaccine was established in 2005 and is the leader in blood products.Hualan BioThe main business is the research and development, production and sales, and operation of human vaccinesHualan BioAll of its vaccine products business.Hualan BioAt the same time, it is a listed company on the A-share market, holding 75% of the equity of Hualan Vaccine, and is the controlling part of the companyshareholder。

As an innovative biopharmaceutical company integrating vaccine research and development and production, Hualan Vaccine developed the world‘s first batch of H1N1 influenza virus split vaccine in 2009, and in 2018 became the first domestic manufacturer of tetravalent influenza virus split vaccine approved. enterprise. At present, Hualan Vaccine has become the largest domestic flu vaccine production and sales company.

After this spin-off and listing, Hualan Biology and other subsidiaries (except Hualan Vaccine) will continue to focus on the development of businesses other than vaccine research and development, production and sales, highlight the company’s business advantages in blood products and other aspects, and further strengthen the company Independence.

On March 26, 2020, Hualan vaccine was introduced into the war. Hillhouse Capital and Morning One Fund invested 1.242 billion and 828 million respectively, and acquired 15% of Hualan Vaccine.

Less than a month after the introduction of the war investment, Hualan Vaccine planned to be listed on the Growth Enterprise Market independently. Based on the capital contribution and the transferred shares, Hillhouse Capital and Morning One Fund valued Hualan Vaccine at a valuation of 13.8 billion. After the transfer is completed, Hualan Vaccine has a total of 4 shareholders. Among them, the controlling shareholder Hualan Biological holds 75%, the second shareholder Kekang Co., Ltd. holds 10%, Hillhouse Capital and Morning One Fund hold 9% and 6% of the shares respectively.

　　Behind Morning One Fund

　　really miss you200 million yuan subscription

With the successful completion of Hualan Vaccine, the IPO success is only one step away. Once Hualan Vaccine successfully enters the capital market, Hillhouse Capital and Morning One Fund, which invested last year, will undoubtedly become “winners in life.”And those who participated in the subscription of Morning One Fundreally miss youNaturally, you can also experience the gains from indirect investment.

I miss you so much on August 4, 2020announcementAccording to the report, the company held the 16th meeting of the fourth board of directors on August 3, 2020, and reviewed and approved the “Proposal on Participating in the Subscription of Private Equity Fund Shares”, and agreed that the company as a limited partner to Beijing ChenyiM&AThe fund (limited partnership) subscribed to contribute RMB 200 million and signed the “Beijing Morning One M&A Fund (Limited Partnership) Partnership Agreement”.

Regarding the subscription, the relevant person in charge said: “This investment will help the company to increase its capital investment income. At the same time, it will cooperate with Chenyi Fund Management (Beijing) Co., Ltd. The shareholder Chenyi Investment (Beijing) Co., Ltd. (hereinafter referred to as Chenyi Investment) has established a cooperative relationship. In the future, it can use Chenyi Management and Chenyi Investment to invest and finance in domestic and foreign capital markets, as well as M&A.ReorganizationProfessional experience and resources in other fields help the company’s long-term development strategy. “

In January of this year, I really miss you an announcement about the completion of the fundraising of private equity funds participating in the subscription. According to the announcement, the morning One Fund has been raised, with a total of 6.8 billion yuan of funds raised, and the relevant industrial and commercial change registration procedures have been completed.

Nowadays, with the smooth passing of Hualan Vaccine, as an indirect investor who misses you, he can naturally enjoy the tangible benefits of investment.

(Source: Securities Daily)